Condition
NSCLC (Non-small Cell Lung Carcinoma) clinical trials and research
As of November 12, 2026, Find a Trial lists 3 NSCLC (Non-small Cell Lung Carcinoma) clinical trials that are recruiting, at sites in 21 countries (most in China (1), Australia (1), Belgium (1)). By phase: Phase 3 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 21Countries
Newest NSCLC (Non-small Cell Lung Carcinoma) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Firmonertinib with definitive radiotherapy for unresectable Stage III NSCLC with EGFR uncommon mutations | Phase 2 | Changsha, Hunan | Recruiting | Jan 2, 2026 |
| Low‑dose nivolumab plus chemotherapy as first-line treatment for advanced or metastatic non-small cell lung cancer | Phase 3 | Alor Star, Kedah | Recruiting | Jul 3, 2025 |
| Evaluating daraxonrasib for previously treated patients with RAS mutated lung cancer | Phase 3 | Birmingham, Alabama and 198 other locations | Recruiting | Mar 18, 2025 |
All recruiting trials (3)
-
Firmonertinib with definitive radiotherapy for unresectable Stage III NSCLC with EGFR uncommon mutations
This trial tests whether adding Firmonertinib to definitive radiotherapy helps people with unresectable Stage III NSCLC that has uncommon EGFR mutations.
-
Low‑dose nivolumab plus chemotherapy as first-line treatment for advanced or metastatic non-small cell lung cancer
This trial tests whether adding low‑dose nivolumab to standard chemotherapy helps people with advanced or metastatic non‑small cell lung cancer starting first‑line treatment.
-
Evaluating daraxonrasib for previously treated patients with RAS mutated lung cancer
This study is testing if a new drug called daraxonrasib can help people with RAS mutated lung cancer live longer and feel better compared to standard chemotherapy.
Related topics
Quick answers
How many NSCLC (Non-small Cell Lung Carcinoma) clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 21 countries. The most sites are in China (1 trial), Australia (1 trial), Belgium (1 trial), France (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.